GGrantIndex
Sort

78,016 grants matching breast cancer

Long-term Arm Morbidity Following Breast Cancer Treatment

$709,556
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2007 · CA

Neoadjuvant SEMA4D/ICB therapy for melanoma

$709,554
Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA

(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities

$709,538
Margaret M Whalen · Tennessee State University · U54 · FY2023 · CA

Prophytactic surgery in carriers of BRCA 1/2 mutations

$709,500
Timothy R Rebbeck · University Of Pennsylvania · R01 · FY2010 · CA

Functional Analysis of Breast Cancer Susceptibility Genes in Mice

$709,478
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures

$709,469
D Joseph Jerry · University Of Massachusetts Amherst · U01 · FY2016 · ES

Risk Factors for Second Primary Breast Cancer Among DCIS Survivors

$709,424
Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA

Yoga for women with breast cancer undergoing radiotherapy

$709,414
Lorenzo Cohen · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA

Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women

$709,412
Douglas W Billings · Isa Associates, Inc. · R44 · FY2023 · MD

Endoscopic Fine-Needle Polarized Scanning Spectroscopy for Pancreatic Cystic Lesions Diagnosis

$709,403
Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2019 · EB

Biology and genetics of metastatic disease

$709,351
Sohail F. Tavazoie · Rockefeller University · R35 · FY2022 · CA

FOOD (Food to Overcome Outcomes Disparities)

$709,294
Francesca M Gany · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction

$709,292
Melanie R Palomares · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA

SPORE in Lung Cancer

$709,265
Stephen B Baylin · Johns Hopkins University · P50 · FY2009 · CA

Hormonal Regulation of Breast Cancer

$709,148
Jeffrey Rosen · Baylor College Of Medicine · R01 · FY2013 · CA

Metropolitan New York Registry of Breast Cancer Families

$709,126
Mary Beth Terry · Columbia University Health Sciences · U01 · FY2007 · CA

Low Cost Automated Ultrasound for Breast Cancer Detection and Diagnosis

$709,125
Susan M Love · Dr. Susan Love Research Foundation · UH3 · FY2018 · CA

Randomized controlled trial of FoRtitude: Targeted eHealth intervention to reduce fear of recurrence among breast cancer survivors in community oncology settings

$709,050
Lynne I. Wagner · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

HARNESSING INNATE IMMUNITY TO IMPROVE METASTATIC BREAST CANCER THERAPY. THE ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS THROUGH THE BREAST CANCER RESEARCH PROGRAM, ENDORSED BY THE DEPARTMENT OF DEFENSE. THE ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS THROUGH THE BREAST CANCER RESEARCH PROGRAM, ENDORSED BY THE DEPARTMENT OF THE ARMY.

$708,752
Ohio State University, The · · FY2022 · Defense Health Agency

OSUCCC CUSP2CT

$708,750
Electra D. Paskett · Ohio State University · U01 · FY2022 · CA

Ontario Familial Breast Cancer Registry

$708,711
Irene L. Andrulis · Cancer Care Ontario · U01 · FY2007 · CA

Flexible versus Standard Aerobic Training Dosing in Primary Breast Cancer: A Randomized and Response-Adapted Trial

$708,646
Jessica Scott · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies

$708,614
Smita Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA

Genomic targets of oncoproteins and tumor suppressors

$708,606
Kevin Struhl · Harvard Medical School · R01 · FY2011 · CA

DIFFERENTIAL ADAR1 DEPENDENCY IN BREAST CANCER REVEALS THERAPEUTIC OPPORTUNITIES THROUGH REGULATION OF MDM2 AND FERROPTOSIS

$708,603
Washington University, The · · FY2021 · Department of the Army